Key result
Genetic ablation of lncRNA H19 ameliorates post-MI cardiac remodeling by antagonizing YB-1 under hypoxia.
Why the study?
Long non-coding RNA H19 correlates with the risk of coronary artery diseases, but its function in the heart is not well characterized.
The lncRNA H19 promotes cardiac fibrosis and remodeling after myocardial infarction by antagonizing YB-1 and de-repressing Collagen 1A1 expression.
H19 modulation remains investigational post-MI; leaves open translation from rodent models to patients.
Rationale: Long non-coding RNA (lncRNAs) has been identified as a pivotal novel regulators in cardiac development as well as cardiac pathogenesis.lncRNA H19 is known as a fetal gene but it is exclusively abundant in the heart and skeletal muscles in adulthood, and is evolutionarily conserved in humans and mice.It has been reported to possess a significant correlation with the risk of coronary artery diseases.However, the function of H19 is not well characterized in heart.Methods: Loss-of-function and gain-of-function mouse models with left anterior descending coronary artery-ligation surgery were utilized to evaluate the functionality of H19 in vivo.For mechanistic studies, hypoxia condition were exerted in in vitro models to mimic cardiac ischemic injury.Chromatin isolation by RNA immunoprecipitation (ChIRP) was performed to reveal the interacting protein of lncRNA H19.Results: lncRNA H19 was significantly upregulated in the infarct area post-surgery day 4 in mouse model.Ectopic expression of H19 in the mouse heart resulted in severe cardiac dilation and fibrosis.Several extracellular matrix (ECM) genes were significantly upregulated.While genetic ablation of H19 by CRISPR-Cas9 ameliorated post-MI cardiac remodeling with reduced expression in ECM genes.Through chromatin isolation by RNA purification (ChIRP), we identified Y-box-binding protein (YB)-1, a suppressor of Collagen 1A1, as an interacting protein of H19.Furthermore, H19 acted to antagonize YB-1 through direct interaction under hypoxia, which resulted in de-repression of Collagen 1A1 expression and cardiac fibrosis.Conclusions: Together these results demonstrate that lncRNA H19 and its interacting protein YB-1 are crucial for ECM regulation during cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Choong et al. (2019) studied Myocardial infarction and cardiac remodeling. lncRNA H19 modulation (overexpression and knockout) vs. Control (AAV9-GFP or wild-type littermates) was evaluated on Cardiac dilation and fibrosis. Ectopic expression of lncRNA H19 exacerbated cardiac dilation and fibrosis post-myocardial infarction, whereas genetic ablation of H19 ameliorated cardiac remodeling by antagonizing YB-1 under hypoxia.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: